TY - JOUR
T1 - Current perspectives on desmoid tumors
T2 - The mayo clinic approach
AU - Joglekar, Siddharth B.
AU - Rose, Peter S.
AU - Sim, Franklin
AU - Okuno, Scott
AU - Petersen, Ivy
PY - 2011/9
Y1 - 2011/9
N2 - Desmoid tumors are a rare group of locally aggressive, non malignant tumors of fibroblastic origin that can lead to significant morbidity due to local invasion. Despite advances in the understanding of these tumors, their natural history is incompletely understood and the optimal treatment is still a matter of debate. Local control is the main goal of treatment and there has been a change in philosophy regarding the management of these tumors from aggressive surgical resection to function preservation. A multidisciplinary approach is essential to plan local control with acceptable morbidity. The current Mayo Clinic algorithm for the treatment of these tumors is based on institutional experience and the available evidence in the literature: asymptomatic/non progressive lesions away from vital structures are managed with observation and regular imaging; primary or recurrent desmoid tumors which are symptomatic or progressive or near vital structures are managed with wide surgical resection when wide surgical margins are possible with minimal functional and cosmetic loss. When positive or close surgical margins are likely, surgical resection with adjuvant radiotherapy or definitive radiotherapy is preferred. If likely functional or cosmetic deficit is unacceptable, radiotherapy is the treatment of choice. Unresectable lesions are considered for radiotherapy, chemotherapy or newer modalities however an unresectable lesion associated with a painful, functionless, infected extremity is managed with an amputation.
AB - Desmoid tumors are a rare group of locally aggressive, non malignant tumors of fibroblastic origin that can lead to significant morbidity due to local invasion. Despite advances in the understanding of these tumors, their natural history is incompletely understood and the optimal treatment is still a matter of debate. Local control is the main goal of treatment and there has been a change in philosophy regarding the management of these tumors from aggressive surgical resection to function preservation. A multidisciplinary approach is essential to plan local control with acceptable morbidity. The current Mayo Clinic algorithm for the treatment of these tumors is based on institutional experience and the available evidence in the literature: asymptomatic/non progressive lesions away from vital structures are managed with observation and regular imaging; primary or recurrent desmoid tumors which are symptomatic or progressive or near vital structures are managed with wide surgical resection when wide surgical margins are possible with minimal functional and cosmetic loss. When positive or close surgical margins are likely, surgical resection with adjuvant radiotherapy or definitive radiotherapy is preferred. If likely functional or cosmetic deficit is unacceptable, radiotherapy is the treatment of choice. Unresectable lesions are considered for radiotherapy, chemotherapy or newer modalities however an unresectable lesion associated with a painful, functionless, infected extremity is managed with an amputation.
KW - Aggressive fibromatosis
KW - Deep fibromatosis
KW - Desmoids
KW - Familial adenomatous polyposis
KW - Fibromatosis
UR - http://www.scopus.com/inward/record.url?scp=80053176855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053176855&partnerID=8YFLogxK
U2 - 10.3390/cancers3033143
DO - 10.3390/cancers3033143
M3 - Review article
C2 - 24212949
AN - SCOPUS:80053176855
SN - 2072-6694
VL - 3
SP - 3143
EP - 3155
JO - Cancers
JF - Cancers
IS - 3
ER -